Undervalued Health Stocks

In 2012 the S&P 500 reported a 13% return, and investors are forecasting another good year for 2013. Here are five health-related stocks with huge upside, according to Goldman Sachs.

In 2012 the S&P 500 reported a 13% return, much better than some other stock markets in the world. And investors are proving to be perpetually optimistic, forecasting the market will do surprisingly well in 2013, as well.

Goldman Sachs’ equity strategy team released a list of stocks with the most upside given Goldman analysts’ price targets. The 40 stocks on the list offer 24% to 44% upside.

The list offers a large number of energy companies, which isn’t surprising given the fact that investors are looking to get in on America’s move toward energy independence.

Here, we’ve pulled five health-related stocks for your consideration.

(Stocks listed in alphabetical order)

Alexion Pharmaceuticals

Symbol: ALXN

Current Price: $96.80

Upside to target: 28%

A pharmaceutical company looking to develop cures for severe, life-threatening and rare diseases.

Edwards Lifesciences

Symbol: EW

Current Price: $91.79

Upside to target: 24.2%

The company designs, manufactures and markets tissue heart valves and hemodynamic monitoring devices.

PerkinElmer

Symbol: PKI

Current Price: $33.08

Upside to target: 26%

A leader in human and environmental health, offering therapeutic and disease research, prenatal screening, environmental testing and industrial monitoring.

Prudential Financial

Symbol: PRU

Current Price: $56.15

Upside to target: 36.9%

A financial services and insurance firm offering life insurance and long-term care insurance.

Stryker Corp.

Symbol: SYK

Current Price: $56.65

Upside to target: 24%

A medical device and equipment manufacturer specializing in orthopedic medical technology.

Read the full list here